Albany, NY -- (SBWIRE) -- 10/04/2017 -- The global hematopoietic stem cells transplantation (HSCT) market to grow at a CAGR of 5.75% during the period 2017-2021.

HSCT is the most widely used stem-cell therapy, where blood from umbilical cord is used. Research is being undertaken to discover various sources (such as cord blood cells, bone marrow, and peripheral blood cells) of hematopoietic stem cells to treat various disorders like hematological malignancies, blood related disorders (leukemia and lymphoma), neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.

Stem-cell therapy has become controversial after developments in isolating and culturing of embryonic stem cells. Somatic cell nuclear transfer is the technique used in embryonic stem cell research to create stem cells and induced pluripotent stem cells. This controversy is related to abortion policies and human cloning. However, the changing regulatory landscape in countries like the US and Japan may help to accelerate the clinical trials.

Covered in this report
The report covers the present scenario and the growth prospects of the global hematopoietic stem cells transplantation (HSCT) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of hematopoietic stem cells transplantation (HSCT).

Get the Sample Copy Of this Report : https://www.marketresearchreports.biz/sample/sample/1336387

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AllCells
Lonza
Merck
Sanofi
Other prominent vendors
Athersys
Beike Biotechnology
BioTime
bluebird bio
Caladrius
Cellular Biomedicine Group
Cellular Dynamics International (a subsidiary of Fujifilm)
Cesca Therapeutics
CHA Biotech
CORESTEM
Gamida Cell
Global Stem Cells Group
Hemostemix
Histocell
Mesoblast
TiGenix
Translational Biosciences (a subsidiary of Medistem Panama)

Market driver
Rising number of HSCT
For a full, detailed list, view our report

Send An Enquiry : https://www.marketresearchreports.biz/sample/enquiry/1336387

Market challenge
High cost of HSCT
For a full, detailed list, view our report

Market trend
Growing demand for personalized medicine
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz